Fuller & Thaler Asset Management
PGNX

Fuller & Thaler Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-312,800
Closed -$2.52M – 778
2018
Q2 		$2.52M Sell
312,800
-100
-0% -$763 0.03% 282
2018
Q1 		$2.33M Sell
312,900
-24,900
-7% -$166K 0.03% 262
2017
Q4 		$2.01M Sell
337,800
-106,400
-24% -$646K 0.02% 264
2017
Q3 		$3.27M Sell
444,200
-2,100
-0.5% -$13.3K 0.04% 202
2017
Q2 		$3.03M Sell
446,300
-1,700
-0.4% -$12.6K 0.04% 189
2017
Q1 		$4.23M Hold
448,000
– – 0.06% 162
2016
Q4 		$3.87M Hold
448,000
– – 0.06% 161
2016
Q3 		$2.84M Sell
448,000
-12,900
-3% -$78K 0.05% 173
2016
Q2 		$1.95M Buy
460,900
+100
+0% +$483 0.03% 192
2016
Q1 		$2.01M Sell
460,800
-147,100
-24% -$655K 0.04% 180
2015
Q4 		$3.73M Buy
607,900
+29,200
+5% +$191K 0.08% 159
2015
Q3 		$3.31M Buy
578,700
+400
+0.1% +$3.07K 0.09% 156
2015
Q2 		$4.31M Buy
578,300
+12,100
+2% +$73.2K 0.12% 142
2015
Q1 		$3.39M Sell
566,200
-1,800
-0.3% -$11.3K 0.11% 171
2014
Q4 		$4.29M Buy
568,000
+8,500
+2% +$50.9K 0.15% 148
2014
Q3 		$2.9M Hold
559,500
– – 0.12% 169
2014
Q2 		$2.41M Buy
559,500
+53,500
+11% +$204K 0.1% 186
2014
Q1 		$2.07M Buy
+506,000
New +$2.59M 0.1% 205

Other funds holding PGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Fuller & Thaler Asset Management's PGNX Position: Q3 2018 in Review

Fuller & Thaler Asset Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q3 2018, closing a stake of 312,800 shares — an estimated $2.52M sold.

Fuller & Thaler Asset Management first reported a position in PGNX in Q1 2014 and held it in 18 quarters. The position peaked at $4.31M in Q2 2015. 149 funds tracked by Wall St. Rank hold PGNX as of Q3 2018.

  • Fuller & Thaler Asset Management reported no remaining Progenics Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 312,800 Progenics Pharmaceuticals Inc shares in Q3 2018, an estimated $2.52M.
  • Fuller & Thaler Asset Management first reported a position in Progenics Pharmaceuticals Inc in Q1 2014 and held it in 18 quarters.
  • Fuller & Thaler Asset Management's Progenics Pharmaceuticals Inc position peaked at $4.31M in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q3 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.